Trends in linezolid susceptibility patterns: report from the 2002–2003 worldwide Zyvox Annual Appraisal of Potency and Spectrum (ZAAPS) Program
- 31 July 2005
- journal article
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 26 (1) , 13-21
- https://doi.org/10.1016/j.ijantimicag.2005.02.019
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Antimicrobial Resistance to LinezolidClinical Infectious Diseases, 2004
- Linezolid Resistance since 2001: SENTRY Antimicrobial Surveillance ProgramAnnals of Pharmacotherapy, 2003
- Linezolid-resistant Enterococcus faecium isolated from a patient without prior exposure to an oxazolidinone: report from the SENTRY Antimicrobial Surveillance ProgramDiagnostic Microbiology and Infectious Disease, 2002
- Oxazolidinone antibioticsThe Lancet, 2001
- Vancomycin‐ResistantEnterococcus faeciumMeningitis Successfully Managed with Linezolid: Case Report and Review of the LiteratureClinical Infectious Diseases, 2001
- The Discovery of Linezolid, the First Oxazolidinone Antibacterial AgentCurrent Drug Targets - Infectious Disorders, 2001
- Linezolid resistance in a clinical isolate of Staphylococcus aureusThe Lancet, 2001
- Successful Treatment of Vancomycin-Resistant Enterococcus Endocarditis with Oral LinezolidClinical Infectious Diseases, 2001
- Infections due to vancomycin-resistant Enterococcus faecium resistant to linezolidThe Lancet, 2001
- In vitro activity of linezolid against multiply resistant Gram-positive clinical isolatesJournal of Antimicrobial Chemotherapy, 2001